(19)
(11) EP 4 437 544 A1

(12)

(43) Date of publication:
02.10.2024 Bulletin 2024/40

(21) Application number: 22821934.1

(22) Date of filing: 22.11.2022
(51) International Patent Classification (IPC): 
G16B 20/00(2019.01)
 G16B 40/20(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 40/20; G16B 20/00
(86) International application number:
PCT/EP2022/082845
(87) International publication number:
WO 2023/089203 (25.05.2023 Gazette 2023/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.11.2021 US 202163281970 P

(71) Applicant: Centre Hospitalier Universitaire Vaudois
1011 Lausanne (CH)

(72) Inventors:
  • BASSANI-STERNBERG, Michal
    1066 Epalinges (CH)
  • MULLER, Markus
    1066 Epalinges (CH)
  • HUBER, Florian
    1066 Epalinges (CH)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) METHODS FOR PREDICTING IMMUNOGENICITY OF MUTATIONS OR NEOANTIGENIC PEPTIDES IN TUMORS